氨溴索联合阿洛西林钠治疗小儿支气管肺炎的临床效果分析  

Analysis of the Clinical Effect of Ambroxol Combined with Aloxicillin Sodium Treatment on Pediatric Bronchopneumonia

作　　者：安鹏程 An Pengcheng(Zhengning County People’s Hospital, Zhengning 745300, China)

机构地区：[1]正宁县人民医院,甘肃正宁745300

出　　处：《黑龙江科学》2022年第2期110-111,共2页Heilongjiang Science

摘　　要：分析氨溴索联合阿洛西林钠治疗小儿支气管肺炎的临床效果。随机选择55例小儿支气管肺炎患者,分为比较组和治疗组,观察两组的临床疗效,比较治疗后两组的炎症因子水平。结果表明,治疗组的临床疗效显著优于比较组(P<0.05);治疗组的IL-6、CRP水平均显著低于比较组(P<0.05)。氨溴索联合阿洛西林钠治疗小儿支气管肺炎,可显著降低患儿机体的炎症因子水平,改善临床症状。The research analyzes the clinical effect of ambroxol combined with aloxicillin sodium treatment on pediatric bronchopneumonia.55 children with bronchopneumonia are randomly selected,and they are divided into control group and treatment group.Clinical effect of two groups is observed,and the inflammatory factors of two groups after treatment are compared.The results show that the clinical effect of treatment group is significantly better than control group(P<0.05).IL-6 and CRP level of treatment group are significantly lower than control group(P<0.05).Ambroxol combined with aloxicillin sodium treatment on pediatric bronchopneumonia can significantly reduce the inflammatory factor level,and improve clinical symptoms.

关 键 词：小儿支气管肺炎 氨溴索 阿洛西林钠 炎症因子 临床效果 

分 类 号：R725.6[医药卫生—儿科]